Abstract
Radiation therapy uses high-energy ionizing radiation beams to treat malignant cancers as well as a variety of benign tumors and medical conditions. James Ewing was the first to report the successful use of radiotherapy in the management of unresectable desmoid tumors in 1928 [1]. Since then several studies have shown excellent control rates with radiation, which indicate a role for radiotherapy in the multidisciplinary management of these nonmalignant tumors [2–6]. Currently, radiation can be used as the primary treatment for desmoids, as an adjunct to surgery, and as the treatment of recurrent disease.
Surgery has generally been the standard initial modality for treating patients with desmoid tumors, although experience is accumulating with a more conservative approach of initial observation, deferring surgery or other treatment until there is evidence of progression [7, 8]. Optimizing local control is the key element for the curative treatment of these benign tumors, given their inability to metastasize and the expectation of long-term survival for most patients. This underlies the rationale for combining surgical resection and radiotherapy with the goal of improving local control and to limit the morbidity associated with recurrence in some patients. Despite the large number of published series examining the effect of adding radiation to surgery, there is a lack of consensus on the indications for such an approach. Furthermore, due to the low incidence of desmoids, there are no randomized controlled trials comparing the effect of different treatment modalities in the management of desmoid tumors. In the absence of such high-level evidence, the application of radiation in the management of desmoids is based upon effectiveness seen in retrospective and phase II studies. In most of these studies, radiation has been used largely in patients who have recurred after initial surgery and as primary treatment in those patients who are medically inoperable or those in whom resection presents unacceptable morbidity [9–12]. However, because there are other treatment modalities available for the management of desmoids, the use of radiotherapy must be considered carefully in light of the potential long-term side effects of radiotherapy including the risk of secondary malignancy, particularly in younger patients. Table 8.1 outlines the principles of irradiating nonmalignant diseases, which applies to the use of radiation in this disease [13]. Ultimately, treatment decisions are individualized to each patient depending on a range of patient and tumor characteristics [8, 14]. In Fig. 8.1, we outline a treatment algorithm that we have found useful in managing patients with desmoid tumors.
In this chapter, we discuss separately the role of radiation in the treatment of primary and recurrent desmoid tumors. We will also review the basics of radiation treatment planning and the different radiation techniques that can be applied.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ewing J (1928) Neoplastic disease. WB Saunders, Philadelphia
Ballo MT, Zagars GK, Pollack A (1998) Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 42(5):1007–1014. doi:S0360-3016(98)00285-5 [pii]
Guadagnolo BA, Zagars GK, Ballo MT (2008) Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys 71(2):441–447. doi:S0360-3016(07)04425-2 [pii] 10.1016/j.ijrobp.2007.10.013
Jelinek JA, Stelzer KJ, Conrad E, Bruckner J, Kliot M, Koh W, Laramore GE (2001) The efficacy of radiotherapy as postoperative treatment for desmoid tumors. Int J Radiat Oncol Biol Phys 50(1):121–125. doi:S0360301600015704 [pii]
Nuyttens JJ, Rust PF, Thomas CR, Jr, Turrisi AT, 3rd (2000) Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer 88(7):1517–1523. doi:10.1002/(SICI)1097-0142(20000401)88:7-1517::AID-CNCR3-3.0.CO;2-9 [pii]
Acker JC, Bossen EH, Halperin EC (1993) The management of desmoid tumors. Int J Radiat Oncol Biol Phys 26(5):851–858
Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA (1999) Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 17(1):158–167
de Bree E, Keus R, Melissas J, Tsiftsis D, van Coevorden F (2009) Desmoid tumors: need for an individualized approach. Expert Rev Anticancer Ther 9(4):525–535. doi:10.1586/era.09.9
Baumert BG, Spahr MO, Von Hochstetter A, Beauvois S, Landmann C, Fridrich K, Villa S, Kirschner MJ, Storme G, Thum P, Streuli HK, Lombriser N, Maurer R, Ries G, Bleher EA, Willi A, Allemann J, Buehler U, Blessing H, Luetolf UM, Davis JB, Seifert B, Infanger M (2007) The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat Oncol 2:(12). doi:1748-717X-2-12 [pii] 10.1186/1748-717X-2-12
Gluck I, Griffith KA, Biermann JS, Feng FY, Lucas DR, Ben-Josef E (2010) Role of radiotherapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys. doi:S0360-3016(10)00416-5 [pii] 10.1016/j.ijrobp.2010.02.053
Zlotecki RA, Scarborough MT, Morris CG, Berrey BH, Lind DS, Enneking WF, Marcus RB Jr (2002) External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 54(1):177–181. doi:S0360301602029267 [pii]
Micke O, Seegenschmiedt MH (2005) Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national Patterns of Care Study. Int J Radiat Oncol Biol Phys 61(3):882–891. doi:S0360-3016(04)02101-7 [pii] 10.1016/j.ijrobp.2004.07.705
Micke O, Seegenschmiedt MH (2002) Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys 52(2):496–513. doi:S0360301601018144 [pii]
Hosalkar HS, Fox EJ, Delaney T, Torbert JT, Ogilvie CM, Lackman RD (2006) Desmoid tumors and current status of management. Orthop Clin North Am 37(1):53–63. doi:S0030-5898(05)00077-5 [pii] 10.1016/j.ocl.2005.08.004
Rontgen WK (1896) A new form of radiation. Science 3(72):726–729. doi:3/72/726 [pii] 10.1126/science.3.72.726
Hall EJ, Giaccia AJ (2005) Radiobiology for the radiologist, 6th edn. Lippincott Williams & Wilkins, Philadelphia
Serber W, Bracy, LW, Zhang, M, Hoppe, RT (2004) Radiation treatment of benign disease. In: Perez C, Brady LW, Halperin EG, Schmidt-Ullrich R (eds) Principles and practice of radiation oncology, 4th edn. Lippincott Williams and Wilkins, Philadelphia
Bhide SA, Nutting CM (2010) Recent advances in radiotherapy. BMC Med 8:25. doi:1741-7015-8-25 [pii] 10.1186/1741-7015-8-25
Connell PP, Hellman S (2009) Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res 69(2):383–392. doi:69/2/383 [pii] 10.1158/0008-5472.CAN-07-6871
Fenwick JD, Riley SW, Scott AJ (2008) Advances in intensity-modulated radiotherapy delivery. Cancer Treat Res 139:193–214
Jenkins NH, Freedman LS, McKibbin B (1986) Spontaneous regression of a desmoid tumour. J Bone Joint Surg Br 68(5):780–781
Lazar AJ, Hajibashi S, Lev D (2009) Desmoid tumor: from surgical extirpation to molecular dissection. Curr Opin Oncol 21(4):352–359. doi:10.1097/CCO.0b013e32832c9502
Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173(5):1518–1527. doi:ajpath.2008.080475 [pii] 10.2353/ajpath.2008.080475
Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, Juillard GJ, Selch MT (1997) The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 39(3):659–665. doi:S0360-3016(97)00334-9 [pii]
Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF (1999) Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 86(10):2045–2052. doi:10.1002/(SICI)1097-0142(19991115)86:10-2045::AID-CNCR23-3.0.CO;2-F [pii]
Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS, Pollock RE (2007) Optimizing treatment of desmoid tumors. J Clin Oncol 25(13):1785–1791. doi:25/13/1785 [pii] 10.1200/JCO.2006.10.5015
Spear MA, Jennings LC, Mankin HJ, Spiro IJ, Springfield DS, Gebhardt MC, Rosenberg AE, Efird JT, Suit HD (1998) Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40(3):637–645. doi:S0360301697008456 [pii]
Gronchi A, Casali PG, Mariani L, Lo Vullo S, Colecchia M, Lozza L, Bertulli R, Fiore M, Olmi P, Santinami M, Rosai J (2003) Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 21(7):1390–1397
Singh G, Syed SP, Tome M et al. (2008) Prognostic value of margin status in the treatment of desmoid tumor [abstract]. Int J Radiat Oncol Biol Phys 72(Suppl 1):107–108
Melis M, Zager JS, Sondak VK (2008) Multimodality management of desmoid tumors: how important is a negative surgical margin? J Surg Oncol 98(8):594–602. doi:10.1002/jso.21033
Kamath SS, Parsons JT, Marcus RB, Zlotecki RA, Scarborough MT (1996) Radiotherapy for local control of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 36(2):325–328. doi:S0360301696003215 [pii]
McCollough WM, Parsons JT, Van Der Griend R, Enneking WF, Heare T (1991) Radiation therapy for aggressive fibromatosis. The experience at the University of Florida. J Bone Joint Surg Am 73(5):717–725
Stoeckle E, Coindre JM, Longy M, Binh MB, Kantor G, Kind M, de Lara CT, Avril A, Bonichon F, Bui BN (2009) A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases. Eur J Surg Oncol 35(2):129–134. doi:S0748-7983(08)01713-7 [pii] 10.1016/j.ejso.2008.06.1495
Latchford AR, Sturt NJ, Neale K, Rogers PA, Phillips RK (2006) A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg 93(10):1258–1264. doi:10.1002/bjs.5425
Seow-Choen F (2008) The management of desmoids in patients with familial adenomatous polyposis (FAP). Acta Chir Iugosl 55(3):83–87
O’Dea FJ, Wunder J, Bell RS, Griffin AM, Catton C, O’Sullivan B (2003) Preoperative radiotherapy is effective in the treatment of fibromatosis. Clin Orthop Relat Res 415:19–24. doi:10.1097/01.blo.0000093892.12372.d4
Baliski CR, Temple WJ, Arthur K, Schachar NS (2002) Desmoid tumors: a novel approach for local control. J Surg Oncol 80(2):96–99. doi:10.1002/jso.10104
Sorensen A, Keller J, Nielsen OS, Jensen OM (2002) Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1-27 years. Acta Orthop Scand 73(2):213–219. doi:10.1080/000164702753671830
Fontanesi J, Mott MP, Kraut MJ, Lucas DP, Miller PR (2004) The role of postoperative irradiation in the treatment of locally recurrent incompletely resected extra-abdominal desmoid tumors. Sarcoma 8(2–3):83–86. doi:10.1080/13577140410001710512
Suit H, Spiro I (2001) Radiation in the multidisciplinary management of desmoid tumors. Front Radiat Ther Oncol 35:107–119
Suit HD (1990) Radiation dose and response of desmoid tumors. Int J Radiat Oncol Biol Phys 19(1):225–227
Merchant TE, Nguyen D, Walter AW, Pappo AS, Kun LE, Rao BN (2000) Long-term results with radiation therapy for pediatric desmoid tumors. Int J Radiat Oncol Biol Phys 47(5):1267–1271. doi:S0360-3016(00)005666 [pii]
Jabbari S, Andolino D, Weinberg V, Missett BT, Law J, Wara WM, O’Donnell RJ, Matthay KK, DuBois SG, Goldsby R, Haas-Kogan DA (2009) Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy. Int J Radiat Oncol Biol Phys 75(1):177–182. doi:S0360-3016(08)03865-0 [pii] 10.1016/j.ijrobp.2008.10.072
Skapek SX, Ferguson WS, Granowetter L, Devidas M, Perez-Atayde AR, Dehner LP, Hoffer FA, Speights R, Gebhardt MC, Dahl GV, Grier HE (2007) Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol 25(5):501–506. doi:25/5/501 [pii] 10.1200/JCO.2006.08.2966
Miralbell R, Lomax A, Cella L, Schneider U (2002) Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 54(3):824–829. doi:S0360301602029826 [pii]
Perez C, Brady, LW, Halperin, EG, Schmidt-Ullrich, R (2004) Principles and practice of radiation oncology, 4th edn. Lippincott, Williams and Wilkins, Philadelphia
Dawson LA, Jaffray DA (2007) Advances in image-guided radiation therapy. J Clin Oncol 25(8):938–946. doi:25/8/938 [pii] 10.1200/JCO.2006.09.9515
Devlin PM (2006) Brachytherapy: applications and techniques, 1st edn. Lippincott Williams & Wilkins, Philadelphia
Assad WA, Nori D, Hilaris BS, Shiu MH, Hajdu SI (1986) Role of brachytherapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 12(6):901–906
Alektiar KM, Leung D, Zelefsky MJ, Healey JH, Brennan MF (2002) Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremity. Ann Surg Oncol 9(1):48–56
Roeder F, Timke C, Oertel S, Hensley FW, Bischof M, Muenter MW, Weitz J, Buchler MW, Lehner B, Debus J, Krempien R (2010) Intraoperative electron radiotherapy for the management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 76(4):1154–1160. doi:S0360-3016(09)00608-7 [pii] 10.1016/j.ijrobp.2009.03.067
Radiation Therapy Oncology Group (RTOG) acute radiation morbidity scoring criteria. http://208.251.169.72/members/toxicity/acute.html. Accessed 3 July 2011
Radiation Therapy Oncology Group (RTOG), European Organization for Research and Treatment of Cancer (EORTC) late radiation morbidity scoring schema. http://208.251.169.72/members/toxicity/late.html. Accessed 3 July 2011
NCI National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) toxicity schemas. http://www.eortc.be/services/doc/ctc/default.htm. Accessed 3 July 2011
Jansen JT, Broerse JJ, Zoetelief J, Klein C, Seegenschmiedt HM (2005) Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel. Radiother Oncol 76(3):270–277. doi:S0167-8140(05)00275-6 [pii] 10.1016/j.radonc.2005.06.034
National Comprehensive Cancer Network (NCCN) treatment guidelines. www.nccn.org
Park HC, Pyo HR, Shin KH, Suh CO (2003) Radiation treatment for aggressive fibromatosis: findings from observed patterns of local failure. Oncology 64(4):346–352. doi:10.1159/000070292 OCL2003064004346 [pii]
Schulz-Ertner D, Zierhut D, Mende U, Harms W, Branitzki P, Wannenmacher M (2002) The role of radiation therapy in the management of desmoid tumors. Strahlenther Onkol 178(2):78–83
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Al-Halabi, H.O., Chen, YL., Mullen, J.T., Yoon, S.S., Hornicek, F.J., DeLaney, T.F. (2012). Radiation Therapy for Desmoid Tumors. In: Litchman, C. (eds) Desmoid Tumors. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1685-8_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-1685-8_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1684-1
Online ISBN: 978-94-007-1685-8
eBook Packages: MedicineMedicine (R0)